SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer - Concepedia

Concepedia

Publication | Open Access

SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer

DOI Full Paper Access

23

Citations

18

References

2019

Year

Yoshinori Munemoto, Masato Nakamura, Masazumi Takahashi, Masahito Kotaka, Hiroyuki Kuroda, Takeshi Kato, Nozomi Minagawa, S. Noura, Masashi Fukunaga, Hidekazu Kuramochi,

European Journal of Cancer

Abstract

NCT02337946.

References

	Year	Citations

Page 1